DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
Hemostasis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hemostasis Key assessments Patient Segmentation in Hemostasis Hemostasis Risk & Burden Factors driving growth in a specific Hemostasis patient population
January 2022
60 pages
Hepatitis A - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hepatitis A Key assessments Patient Segmentation in Hepatitis A Hepatitis A Risk & Burden Factors driving growth in a specific Hepatitis A patient population
January 2022
60 pages
Hepatitis D - Epidemiology Forecast to 2032
US$ 3,950.00
... Forecast of Hepatitis D epidemiology 8MM Coverage Diagnosed Prevalent cases of Hepatitis D Prevalent Cases according to segmentation: by severity (Fulminant, Acute & Chronic), Gender-Specific, Age-specific and diagnosed prevalent cases of Hepatitis D in 8MM Key assessments Patient Segmentation Disease Risk ...
January 2022
60 pages
Herpes Labialis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Herpes Labialis Key assessments Patient Segmentation in Herpes Labialis Herpes Labialis Risk & Burden Factors driving growth in a specific Herpes Labialis patient population
January 2022
60 pages
Ankylosing Spondylitis - Market Insight, Epidemiology and Market Forecast -2032
US$ 7,500.00
... Hospital Acquired Methicillin-Resistant Staphylococcus Aureus Infections Hospital Acquired Methicillin-Resistant Staphylococcus Aureus Infections Report Key Strengths 10 Year Forecast 7MM Coverage Epidemiology Segmentation Drugs Uptake Highly Analyzed Market Key Cross Competition Hospital Acquired Methicillin ...
January 2022
200 pages
Hot Flashes - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hot Flashes Key assessments Patient Segmentation in Hot Flashes Hot Flashes Risk & Burden Factors driving growth in a specific Hot Flashes patient population
January 2022
60 pages
Hyperkalemia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hyperkalemia Key assessments Patient Segmentation in Hyperkalemia Hyperkalemia Risk & Burden Factors driving growth in a specific Hyperkalemia patient population
January 2022
60 pages
Hyperparathyroidism - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hyperparathyroidism Key assessments Patient Segmentation in Hyperparathyroidism Hyperparathyroidism Risk & Burden Factors driving growth in a specific Hyperparathyroidism patient population
January 2022
60 pages
Hyperphosphatemia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hyperphosphatemia Key assessments Patient Segmentation in Hyperphosphatemia Hyperphosphatemia Risk & Burden Factors driving growth in a specific Hyperphosphatemia patient population
January 2022
60 pages
Hypersomnia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hypersomnia Key assessments Patient Segmentation in Hypersomnia Hypersomnia Risk & Burden Factors driving growth in a specific Hypersomnia patient population
January 2022
60 pages
Hypertriglyceridemia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hypertriglyceridemia Key assessments Patient Segmentation in Hypertriglyceridemia Hypertriglyceridemia Risk & Burden Factors driving growth in a specific Hypertriglyceridemia patient population
January 2022
60 pages
Hyperuricemia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Hyperuricemia Key assessments Patient Segmentation in Hyperuricemia Hyperuricemia Risk & Burden Factors driving growth in a specific Hyperuricemia patient population
January 2022
60 pages
Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2032
US$ 3,950.00
... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Idiopathic Pulmonary Fibrosis Key assessments Patient Segmentation in Idiopathic Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis Risk & Burden Factors driving growth in a specific Idiopathic Pulmonary Fibrosis patient population ...
January 2022
60 pages
Idiopathic Short Stature - Epidemiology Forecast to 2032
US$ 3,950.00
... with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Idiopathic Short Stature Key assessments Patient Segmentation in Idiopathic Short Stature Idiopathic Short Stature Risk & Burden Factors driving growth in a specific Idiopathic Short Stature patient population
January 2022
60 pages
Idiopathic Thrombocytopenic Purpura - Epidemiology Forecast to 2032
US$ 3,950.00
... strengths 10 Year Forecast 7MM Coverage Total Cases in Idiopathic Thrombocytopenic Purpura Key assessments Patient Segmentation in Idiopathic Thrombocytopenic Purpura Idiopathic Thrombocytopenic Purpura Risk & Burden Factors driving growth in a specific Idiopathic Thrombocytopenic Purpura patient population
January 2022
60 pages
Impetigo - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Impetigo Key assessments Patient Segmentation in Impetigo Impetigo Risk & Burden Factors driving growth in a specific Impetigo patient population
January 2022
60 pages
Indolent Lymphoma - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Indolent Lymphoma Key assessments Patient Segmentation in Indolent Lymphoma Indolent Lymphoma Risk & Burden Factors driving growth in a specific Indolent Lymphoma patient population
January 2022
60 pages
Infantile Spasm - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Infantile Spasm Key assessments Patient Segmentation in Infantile Spasm Infantile Spasm Risk & Burden Factors driving growth in a specific Infantile Spasm patient population
January 2022
60 pages
Influenza A Infections - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Influenza A Infections Key assessments Patient Segmentation in Influenza A Infections Influenza A Infections Risk & Burden Factors driving growth in a specific Influenza A Infections patient population
January 2022
60 pages
Intermittent Claudication - Epidemiology Forecast to 2032
US$ 3,950.00
... respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Intermittent Claudication Key assessments Patient Segmentation in Intermittent Claudication Intermittent Claudication Risk & Burden Factors driving growth in a specific Intermittent Claudication patient population
January 2022
60 pages
Iron Deficiency Anemia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Iron Deficiency Anemia Key assessments Patient Segmentation in Iron Deficiency Anemia Iron Deficiency Anemia Risk & Burden Factors driving growth in a specific Iron Deficiency Anemia patient population
January 2022
60 pages
Juvenile Rheumatoid Arthritis - Epidemiology Forecast to 2032
US$ 3,950.00
... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Juvenile Rheumatoid Arthritis Key assessments Patient Segmentation in Juvenile Rheumatoid Arthritis Juvenile Rheumatoid Arthritis Risk & Burden Factors driving growth in a specific Juvenile Rheumatoid Arthritis patient population ...
January 2022
60 pages
Kaposi's Sarcoma - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Kaposi's Sarcoma Key assessments Patient Segmentation in Kaposi's Sarcoma Kaposi's Sarcoma Risk & Burden Factors driving growth in a specific Kaposi's Sarcoma patient population
January 2022
60 pages
Klebsiella Pneumoniae Infections - Epidemiology Forecast to 2032
US$ 3,950.00
... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Klebsiella Pneumoniae Infections Key assessments Patient Segmentation in Klebsiella Pneumoniae Infections Klebsiella Pneumoniae Infections Risk & Burden Factors driving growth in a specific Klebsiella Pneumoniae Infections patient ...
January 2022
60 pages
Left Ventricular Dysfunction - Epidemiology Forecast to 2032
US$ 3,950.00
... the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Left Ventricular Dysfunction Key assessments Patient Segmentation in Left Ventricular Dysfunction Left Ventricular Dysfunction Risk & Burden Factors driving growth in a specific Left Ventricular Dysfunction patient population
January 2022
60 pages
Leishmaniasis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Leishmaniasis Key assessments Patient Segmentation in Leishmaniasis Leishmaniasis Risk & Burden Factors driving growth in a specific Leishmaniasis patient population
January 2022
60 pages
Liposarcoma - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Liposarcoma Key assessments Patient Segmentation in Liposarcoma Liposarcoma Risk & Burden Factors driving growth in a specific Liposarcoma patient population
January 2022
60 pages
Liver Failure - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Liver Failure Key assessments Patient Segmentation in Liver Failure Liver Failure Risk & Burden Factors driving growth in a specific Liver Failure patient population
January 2022
60 pages
Lupus Nephritis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Lupus Nephritis Key assessments Patient Segmentation in Lupus Nephritis Lupus Nephritis Risk & Burden Factors driving growth in a specific Lupus Nephritis patient population
January 2022
60 pages
Male Hypogonadism - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Male Hypogonadism Key assessments Patient Segmentation in Male Hypogonadism Male Hypogonadism Risk & Burden Factors driving growth in a specific Male Hypogonadism patient population
January 2022
60 pages
Malignant Glioma - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Malignant Glioma Key assessments Patient Segmentation in Malignant Glioma Malignant Glioma Risk & Burden Factors driving growth in a specific Malignant Glioma patient population
January 2022
60 pages
Malignant Mesothelioma - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Malignant Mesothelioma Key assessments Patient Segmentation in Malignant Mesothelioma Malignant Mesothelioma Risk & Burden Factors driving growth in a specific Malignant Mesothelioma patient population
January 2022
60 pages
Medullary Thyroid Cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Medullary Thyroid Cancer Key assessments Patient Segmentation in Medullary Thyroid Cancer Medullary Thyroid Cancer Risk & Burden Factors driving growth in a specific Medullary Thyroid Cancer patient population
January 2022
60 pages
Medulloblastoma - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Medulloblastoma Key assessments Patient Segmentation in Medulloblastoma Medulloblastoma Risk & Burden Factors driving growth in a specific Medulloblastoma patient population
January 2022
60 pages
Metastatic Hepatocellular Carcinoma - Epidemiology Forecast to 2032
US$ 3,950.00
... strengths 10 Year Forecast 7MM Coverage Total Cases in Metastatic Hepatocellular Carcinoma Key assessments Patient Segmentation in Metastatic Hepatocellular Carcinoma Metastatic Hepatocellular Carcinoma Risk & Burden Factors driving growth in a specific Metastatic Hepatocellular Carcinoma patient population
January 2022
60 pages
Metastatic Hormone Refractory Prostate Cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Metastatic Hormone Refractory Prostate Cancer Key assessments Patient Segmentation in Metastatic Hormone Refractory Prostate Cancer Metastatic Hormone Refractory Prostate Cancer Risk & Burden Factors driving growth ...
January 2022
60 pages
Metastatic Prostate Cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Metastatic Prostate Cancer Key assessments Patient Segmentation in Metastatic Prostate Cancer Metastatic Prostate Cancer Risk & Burden Factors driving growth in a specific Metastatic Prostate Cancer patient population
January 2022
60 pages
Metastatic Renal Cell Carcinoma (mRCC) - Epidemiology Forecast to 2032
US$ 3,950.00
... Year Forecast 7MM Coverage Total Cases in Metastatic Renal Cell Carcinoma (mRCC) Key assessments Patient Segmentation in Metastatic Renal Cell Carcinoma (mRCC) Metastatic Renal Cell Carcinoma (mRCC) Risk & Burden Factors driving growth in a specific Metastatic Renal Cell Carcinoma (mRCC) patient population
January 2022
60 pages
Moderate Psoriasis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Moderate Psoriasis Key assessments Patient Segmentation in Moderate Psoriasis Moderate Psoriasis Risk & Burden Factors driving growth in a specific Moderate Psoriasis patient population
January 2022
60 pages
Myasthenia Gravis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Myasthenia Gravis Key assessments Patient Segmentation in Myasthenia Gravis Myasthenia Gravis Risk & Burden Factors driving growth in a specific Myasthenia Gravis patient population
January 2022
60 pages
Mycosis Fungoides - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Mycosis Fungoides Key assessments Patient Segmentation in Mycosis Fungoides Mycosis Fungoides Risk & Burden Factors driving growth in a specific Mycosis Fungoides patient population
January 2022
60 pages
Myelofibrosis - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Myelofibrosis Key assessments Patient Segmentation in Myelofibrosis Myelofibrosis Risk & Burden Factors driving growth in a specific Myelofibrosis patient population
January 2022
60 pages
Nasopharyngeal Cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Nasopharyngeal Cancer Key assessments Patient Segmentation in Nasopharyngeal Cancer Nasopharyngeal Cancer Risk & Burden Factors driving growth in a specific Nasopharyngeal Cancer patient population
January 2022
60 pages
Neuroblastoma - Epidemiology Forecast to 2032
US$ 3,950.00
... risk factors, disease burden with special emphasis on the unmet medical needs associated with the Neuroblastoma. The report contains the targeted patient populations and the forecast ...
January 2022
60 pages
Nicotine Addiction - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Nicotine Addiction Key assessments Patient Segmentation in Nicotine Addiction Nicotine Addiction Risk & Burden Factors driving growth in a specific Nicotine Addiction patient population
January 2022
60 pages
Nocturia - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Nocturia Key assessments Patient Segmentation in Nocturia Nocturia Risk & Burden Factors driving growth in a specific Nocturia patient population
January 2022
60 pages
Non Alcoholic Fatty Liver Disease (NAFLD) - Epidemiology Forecast to 2032
US$ 3,950.00
... patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Non Alcoholic Fatty Liver Disease (NAFLD) Key assessments Patient Segmentation in Non Alcoholic Fatty Liver Disease (NAFLD) Non Alcoholic Fatty Liver Disease (NAFLD) Risk & Burden Factors driving growth in a specific Non Alcoholic ...
January 2022
60 pages
Non-Small Cell Lung Cancer - Epidemiology Forecast to 2032
US$ 3,950.00
... to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Non-Small Cell Lung Cancer Key assessments Patient Segmentation in Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer Risk & Burden Factors driving growth in a specific Non-Small Cell Lung Cancer patient population
January 2022
60 pages
Nosocomial Infections - Epidemiology Forecast to 2032
US$ 3,950.00
... 7MM with respect to the patient population Key strengths 10 Year Forecast 7MM Coverage Total Cases in Nosocomial Infections Key assessments Patient Segmentation in Nosocomial Infections Nosocomial Infections Risk & Burden Factors driving growth in a specific Nosocomial Infections patient population
January 2022
60 pages